- AustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
CNBC reports that Vale (NYSE:VALE,SAO:VALE5) has been outbid by Jinchuan Group (FRA:GDZD,ETR:GDZD) for Metorex (JNB:MEMTX,PINK:MRXLY).
CNBC reports that Vale (NYSE:VALE,SAO:VALE5) has been outbid by Jinchuan Group (FRA:GDZD,ETR:GDZD) for Metorex (JNB:MEMTX,PINK:MRXLY).
The market news is quoted as saying,
Although the saga still has at least a week to run, Jinchuan swung a hefty blow this week, with a $1.3 billion bid to trump a $1.1 billion offer from Vale.
Jinchuan’s juicy premium for Metorex, which operates copper and cobalt mines in Zambia and Democratic Republic of Congo, clearly demonstrates the lengths Chinese firms are prepared to go to secure natural resources for ravenous factories back home.
For the complete market news, click here.
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.